America Pharma Source (Apharmas) today announced that it has introduced a novel in vitro cationic lipid transfection reagent, Cellipon293™, for $98.40 per milliliter (mL), only about 30% of cost comparing to major brand products. Cellipon 293™ is specifically developed for the delivery of DNA/RNA into HEK-293 cells as well as a broad range of mammalian cells. This product is based on new lipid technology and exhibits high transfection efficiency, low cytotoxicity, and the best quality/price ratio. The price advantage and simple protocol enable researchers to get satisfactory results easy, fast, and cost-effective, which is critical for low-budget laboratories and high volume users.
